Overview

An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis

Status:
Completed
Trial end date:
2020-11-25
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of NTZ 500mg bid after 24 weeks of treatment in patients with NASH induced Stage 2 or Stage 3 fibrosis
Phase:
Phase 2
Details
Lead Sponsor:
Pinnacle Clinical Research, PLLC
Treatments:
Nitazoxanide